Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The present study aims to compare the pre-emptive analgesic efficacy of parecoxib 40 mg IV/IM
versus placebo on reducing postoperative acute pain following submuscular breast
augmentation. Additionally this study is being conducted to evaluate the safety and
tolerability of parecoxib in this kind of procedure.